More than five decades after it was originally conceptualized as rescue therapy for patients
with intractable variceal bleeding, the transjugular intrahepatic portosystemic shunt (TIPS) …

Patients with cirrhosis and portal hypertension often develop complications from a variety of
organ systems leading to a multiple organ failure. The combination of liver failure and portal …

The natural history of cirrhosis is characterised by an asymptomatic compensated phase
followed by a decompensated phase, marked by the development of overt clinical signs, the …

These guidelines on transjugular intrahepatic portosystemic stent-shunt (TIPSS) in the
management of portal hypertension have been commissioned by the Clinical Services and …

A Prospective Study Identifying Predictive Factors of Cardia... : Hepatology A Prospective
Study Identifying Predictive Factors of Cardiac Decompensation After Transjugular …

Traditionally, the complications of cirrhosis, namely variceal bleeding, ascites and hepatic
encephalopathy, were thought to result predominantly from circulatory dysfunction and …

Cirrhosis is known to cause alterations in the systemic haemodynamic system. Cirrhotic
cardiomyopathy designates a cardiac dysfunction that includes impaired cardiac contractility …

The liver is a crucial metabolic organ that has a key role in maintaining immune and
endocrine homeostasis. Accumulating evidence suggests that chronic liver disease might …

Background and Aims Transjugular intrahepatic portosystemic shunt (TIPS) is now a
standard for the treatment of portal hypertension–related complications. After the TIPS …

Background & Aims The main stages of cirrhosis (compensated and decompensated) have
been sub-staged based on clinical, endoscopic, and portal pressure (determined by the …